ANTISENSE THERAPEUTICS LIMITED (ASX:ANP)
Company
Key Dates
Announcements
ANP - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEOThu, 29 Jun 2006 2:00pm
Executives & Directors
Chairman
Managing Director, CEO
Non Exec. Director
Non Exec. Director
Non Exec. Director
CFO
Investor Relations
Secretary
Please contact the ASX to change these details
Company Podcasts
Annual General Meeting
Tue, 8 Nov 2011
Full Year Results
Thu, 11 Aug 2011
Interim Results
Thu, 17 Feb 2011
Annual General Meeting
Tue, 9 Nov 2010
Quarterly Sales Date
Wed, 27 Oct 2010
Annual General Meeting
Fri, 13 Nov 2009 12:00pm
Full Year Results
Wed, 19 Aug 2009
Interim Results
Thu, 5 Feb 2009
Annual General Meeting
Fri, 31 Oct 2008 10:00am
Interim Results
Mon, 4 Feb 2008
| ATL1103 Development Update | Thu, 9 Feb 2012 |
| Appendix 4C - quarterly | Fri, 27 Jan 2012 |
| Appendix 3B | Mon, 23 Jan 2012 |
| Change of Provider of Share Registry Management Services | Thu, 5 Jan 2012 |
| Appendix 3B | Thu, 22 Dec 2011 |
| ATL1101 for Cancer - Extension of Option to License | Fri, 16 Dec 2011 |
| ATL1103 Successfully Progresses Towards Phase II Trial | Wed, 7 Dec 2011 |
| Trading Halt | Mon, 5 Dec 2011 |
| Appendix 3B | Tue, 29 Nov 2011 |
| Appendix 3B | Fri, 25 Nov 2011 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
